CDKN2A determines mesothelioma cell fate to EZH2 inhibition(10.3389/fonc.2022.1081632, 2021)
FRONTIERS IN ONCOLOGY（2022）
Key words
malignant pleural mesothelioma,EZH2 inhibitor,CDKN2A/p16(ink4a),TG2,multicellular spheroids
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined